Dr. Lallas on Ongoing Trials Investigating Immunotherapy for GU Cancer | OncLive

Dr. Lallas on Ongoing Trials Investigating Immunotherapy for GU Cancer

August 8, 2017

Costas Lallas, MD, professor at Sidney Kimmel Medical College, Thomas Jefferson University Hospital, discusses ongoing trials investigating immunotherapy regimens for patients with genitourinary malignancies.

Costas Lallas, MD, professor at Sidney Kimmel Medical College, Thomas Jefferson University Hospital, discusses ongoing trials investigating immunotherapy regimens for patients with genitourinary malignancies.

There are current ongoing trials investigating the use of checkpoint inhibitors for superficial disease, particularly for patients with bladder cancer, explains Lallas. Additionally, trials looking at immunotherapy combinations are particularly interesting for clinicians.


x